Oppenheimer Maintains Outperform on Lemonade, Raises Price Target to $95

Oppenheimer analyst Jason Helfstein maintains Lemonade (NYSE:LMND) with a Outperform and raises the price target from $85 to $95.

Oppenheimer analyst Jason Helfstein maintains Lemonade (NYSE:LMND) with a Outperform and raises the price target from $85 to $95.

Total
0
Shares
Related Posts